351 related articles for article (PubMed ID: 30690664)
21. α-Synuclein: Multiple System Atrophy Prions.
Woerman AL; Watts JC; Aoyagi A; Giles K; Middleton LT; Prusiner SB
Cold Spring Harb Perspect Med; 2018 Jul; 8(7):. PubMed ID: 28213437
[TBL] [Abstract][Full Text] [Related]
22. Prion-like acceleration of a synucleinopathy in a transgenic mouse model.
Mougenot AL; Nicot S; Bencsik A; Morignat E; Verchère J; Lakhdar L; Legastelois S; Baron T
Neurobiol Aging; 2012 Sep; 33(9):2225-8. PubMed ID: 21813214
[TBL] [Abstract][Full Text] [Related]
23. Propagation of prions causing synucleinopathies in cultured cells.
Woerman AL; Stöhr J; Aoyagi A; Rampersaud R; Krejciova Z; Watts JC; Ohyama T; Patel S; Widjaja K; Oehler A; Sanders DW; Diamond MI; Seeley WW; Middleton LT; Gentleman SM; Mordes DA; Südhof TC; Giles K; Prusiner SB
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4949-58. PubMed ID: 26286986
[TBL] [Abstract][Full Text] [Related]
24. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.
Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI
Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930
[TBL] [Abstract][Full Text] [Related]
25. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
26. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
[TBL] [Abstract][Full Text] [Related]
27. A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models.
Lloyd GM; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Long B; Paterno G; Giasson BI
Acta Neuropathol Commun; 2024 Jun; 12(1):91. PubMed ID: 38858742
[TBL] [Abstract][Full Text] [Related]
28. A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy.
Ishimoto T; Oono M; Kaji S; Ayaki T; Nishida K; Funakawa I; Maki T; Matsuzawa SI; Takahashi R; Yamakado H
Mol Brain; 2024 May; 17(1):28. PubMed ID: 38790036
[TBL] [Abstract][Full Text] [Related]
29. Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson's disease brain extracts in transgenic mice.
Lavenir I; Passarella D; Masuda-Suzukake M; Curry A; Holton JL; Ghetti B; Goedert M
Acta Neuropathol Commun; 2019 Sep; 7(1):148. PubMed ID: 31522685
[TBL] [Abstract][Full Text] [Related]
30. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
31. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
33. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
[TBL] [Abstract][Full Text] [Related]
34. Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.
Perez-Rodriguez D; Kalyva M; Leija-Salazar M; Lashley T; Tarabichi M; Chelban V; Gentleman S; Schottlaender L; Franklin H; Vasmatzis G; Houlden H; Schapira AHV; Warner TT; Holton JL; Jaunmuktane Z; Proukakis C
Acta Neuropathol Commun; 2019 Dec; 7(1):219. PubMed ID: 31870437
[TBL] [Abstract][Full Text] [Related]
35. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
Taylor TN; Potgieter D; Anwar S; Senior SL; Janezic S; Threlfell S; Ryan B; Parkkinen L; Deltheil T; Cioroch M; Livieratos A; Oliver PL; Jennings KA; Davies KE; Ansorge O; Bannerman DM; Cragg SJ; Wade-Martins R
Neurobiol Dis; 2014 Feb; 62():193-207. PubMed ID: 24121116
[TBL] [Abstract][Full Text] [Related]
36. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
[TBL] [Abstract][Full Text] [Related]
37. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.
Kuo YM; Li Z; Jiao Y; Gaborit N; Pani AK; Orrison BM; Bruneau BG; Giasson BI; Smeyne RJ; Gershon MD; Nussbaum RL
Hum Mol Genet; 2010 May; 19(9):1633-50. PubMed ID: 20106867
[TBL] [Abstract][Full Text] [Related]
38. Striatal-Inoculation of α-Synuclein Preformed Fibrils Aggravated the Phenotypes of REM Sleep without Atonia in A53T BAC-SNCA Transgenic Mice.
Okuda S; Nakayama T; Uemura N; Hikawa R; Ikuno M; Yamakado H; Inoue H; Tachibana N; Hayashi Y; Takahashi R; Egawa N
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362177
[TBL] [Abstract][Full Text] [Related]
39. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
40. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
